Quantitative Investment Management LLC reduced its holdings in shares of HCA Holdings, Inc. (NYSE:HCA) by 87.8% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 15,800 shares of the company’s stock after selling 113,900 shares during the quarter. Quantitative Investment Management LLC’s holdings in HCA Holdings were worth $1,377,000 at the end of the most recent reporting period.

Several other hedge funds have also made changes to their positions in HCA. UBS Asset Management Americas Inc. lifted its position in shares of HCA Holdings by 5.8% during the 1st quarter. UBS Asset Management Americas Inc. now owns 1,858,113 shares of the company’s stock worth $165,353,000 after buying an additional 101,837 shares during the last quarter. Envestnet Asset Management Inc. lifted its position in shares of HCA Holdings by 43.6% during the 1st quarter. Envestnet Asset Management Inc. now owns 10,985 shares of the company’s stock worth $976,000 after buying an additional 3,336 shares during the last quarter. SG Americas Securities LLC lifted its position in shares of HCA Holdings by 520.6% during the 1st quarter. SG Americas Securities LLC now owns 156,113 shares of the company’s stock worth $13,892,000 after buying an additional 193,231 shares during the last quarter. Clinton Group Inc. lifted its position in shares of HCA Holdings by 618.9% during the 1st quarter. Clinton Group Inc. now owns 53,037 shares of the company’s stock worth $4,720,000 after buying an additional 45,659 shares during the last quarter. Finally, Victory Capital Management Inc. lifted its position in shares of HCA Holdings by 15.1% during the 1st quarter. Victory Capital Management Inc. now owns 1,607,218 shares of the company’s stock worth $143,026,000 after buying an additional 211,436 shares during the last quarter. Institutional investors and hedge funds own 73.75% of the company’s stock.

Several equities analysts have commented on HCA shares. Zacks Investment Research upgraded HCA Holdings from a “hold” rating to a “buy” rating and set a $97.00 target price for the company in a research report on Thursday, July 13th. Argus started coverage on HCA Holdings in a research report on Wednesday, June 28th. They issued a “buy” rating and a $100.00 target price for the company. Cantor Fitzgerald reiterated a “buy” rating and issued a $95.00 target price on shares of HCA Holdings in a research report on Wednesday, September 6th. KeyCorp reiterated a “buy” rating and issued a $95.00 target price on shares of HCA Holdings in a research report on Thursday, September 7th. Finally, Robert W. Baird reiterated a “buy” rating on shares of HCA Holdings in a research report on Thursday. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and twelve have issued a buy rating to the stock. HCA Holdings presently has a consensus rating of “Buy” and an average price target of $92.88.

In other news, insider Michael S. Cuffe sold 2,150 shares of the business’s stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $79.87, for a total value of $171,720.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In the last three months, insiders sold 6,450 shares of company stock valued at $529,309. 2.90% of the stock is currently owned by corporate insiders.

Shares of HCA Holdings, Inc. (NYSE:HCA) opened at 79.59 on Friday. The firm has a market cap of $28.75 billion, a PE ratio of 10.67 and a beta of 0.67. The stock has a 50 day moving average price of $78.44 and a 200 day moving average price of $83.29. HCA Holdings, Inc. has a 52 week low of $67.00 and a 52 week high of $91.03.

HCA Holdings (NYSE:HCA) last released its earnings results on Tuesday, July 25th. The company reported $1.75 earnings per share for the quarter, missing analysts’ consensus estimates of $1.80 by ($0.05). HCA Holdings had a net margin of 6.64% and a negative return on equity of 48.08%. The company had revenue of $10.73 billion during the quarter, compared to the consensus estimate of $10.76 billion. During the same period last year, the firm posted $1.66 EPS. The company’s revenue was up 4.0% on a year-over-year basis. Equities analysts expect that HCA Holdings, Inc. will post $7.18 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: “HCA Holdings, Inc. (HCA) Position Decreased by Quantitative Investment Management LLC” was originally published by Watch List News and is the sole property of of Watch List News. If you are reading this news story on another publication, it was stolen and reposted in violation of international trademark and copyright legislation. The correct version of this news story can be read at https://www.watchlistnews.com/hca-holdings-inc-hca-position-decreased-by-quantitative-investment-management-llc/1600493.html.

HCA Holdings Company Profile

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Holdings, Inc. (NYSE:HCA).

Institutional Ownership by Quarter for HCA Holdings (NYSE:HCA)

Receive News & Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.